Reports

Ideas That Generate Results

Indian Biotechnology Market Outlook (2006)

Indian Biotechnology Market Outlook (2006)

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Feb, 2007| No. of Pages : 90

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1400.00  700.00
CD-ROM Mail Delivery
US$ 1600.00  800.00
Hard Copy Mail Delivery
US$ 1600.00  800.00
Electronic Access - Multi-User License
US$ 1800.00  900.00
List of Figures:
 
Figure 3-1: Worldwide - Biotechnology Market (in Billion US$), 2001-2006E  
Figure 3-2: Worldwide - Biotechnology Market Share by Region (%), 2005  
Figure 3-3: Worldwide - Biotechnology Market Share by Segment (%), 2005      
Figure 3-4: Worldwide - Forecast for Biotechnology Market (in Billion US$), 2007-2010      
Figure 3-5: Asia-Pacific - Biotechnology Market (in Billion US$), 2001-2005     
Figure 3-6: Asia-Pacific - Biotechnology Market Share by Region (%), 2005  
Figure 3-7: Asia-Pacific - Biotechnology Market Share by Segment (%), 2005      
Figure 3-8: Asia-Pacific - Forecast for Biotechnology Market (in Billion US$), 2006-2010     
Figure 3-9: India - Budget Allocations of Major Biotechnology Funding Agencies (in Million US$), 1990-91, 2000-01, 2002-03 to 2004-05         
Figure 4-1: India - Biotechnology Industry Revenue Growth (in Million US$), 2002-03 to 2005-06         
Figure 4-2: India - Market Size of Biotech Industry (in Million US$), 2003-04 to 2005-06         
Figure 4-3: India - Biotechnology Market Share by Segment (%), 2004-05 & 2005-06     
Figure 4-4: India - Domestic Market and Exports Market of Biotech Industry (%), 2005-06         
Figure 4-5: India - Biotech Exports Market Segment (%), 2004-05 & 2005-06         
Figure 4-6: India - Biotech Domestic Market Segment (%), 2004-05 & 2005-06         
Figure 4-7: India - Biotech Domestic Market (in Million US$), 2005-06         
Figure 4-8: India - Bioipharma Segment (%), 2004-05 & 2005-06         
Figure 4-9: India - Revenues from BioPharma (in Million US$), 2004-05 & 2005-06         
Figure 4-10: India - Recombinant Therapeutics Products Market (in Million US$), 2005-06         
Figure 4-11: India - Market Share of BioServices Companies (in Rs Crore), 2005-06         
Figure 4-12: India - Agri Biotech Components’ Market (%), 2004-05         
Figure 4-13: India - BT Cotton Seeds Revenues (in Rs Crore), 2003-04 & 2004-05         
Figure 4-14: India - Industrial Biotech Market (in Million US$), 2003-04 to 2005-06     
Figure 4-15: India - Bio-Industrial Companies Revenue (in Million US$), 2003-04 & 2004-05         
Figure 4-16: India - Industrial Biotech Share by Sector (%), 2005-06         
Figure 4-17: India - Growth in Revenue of Major BioIndustrial Firms (%), 2003 to 2005 
Figure 4-18: India - Bioinformatics Market (in Million US$), 2003-04 to 2006-07E      
Figure 4-19: India - Investments in Biotech Industry (in Million US$), 2000-01 to 2005-06         
Figure 4-20: India - Total Manpower in Biotech Sector (in Numbers), 2002-03 to 2004-05         
Figure 4-21: India - Human Resource Allocation in Biotech Sector (%), 2006      
Figure 5-1: India - Revenue of Biotech Industry by Region (%), 2005-06         
Figure 6-1: India - Forecast for Biotechnology Industry (in Billion US$), 2006-2010     
Figure 7-1: India - Revenue of Top 20 Bio-Suppliers by Region (%), 2004-05         
 
List of Tables:
 
Table 4-1: India - Segment-wise Exports of Biotech Industry (in Million US$), 2005-06          
Table 4-2: India - BT Cotton Sales (in Packets), 2003-2005      
Table 4-3: India - Permitted BT Cotton Seeds  
Table 7-1: India - Revenue of Top 20 Bio-Suppliers (in Rs Crore), 2003-04 & 2004-05
Table 7-2: India - Top 20 Biotech Companies by Revenue (in Rs. Crore), 2005-06       
Table 7-3: Top 20 Biotech Companies of Indian Origin by Revenue (in Rs. Crore), 2004-05 & 2005-06          
Table 7-4: Biocon - Key Financials (in Million Rs), 2004-05 & 2005-06          
Table 7-5: Panacea Biotech - Key Financials (in Million Rs), 2004-05 & 2005-06          
Table 7-6: Nicholas Piramal India Limited - Key Financials (in Million Rs), 2004 &2005   
Table 7-7: Wockhardt Limited - Key Financials (in Billion Rs), 2004 & 2005  
Table 7-8: GlaxoSmithKline - Key Financials (in Million US$), 2004 & 2005  
Table 7-9: Krebs Biochemical’s & Industries Limited - Key Financial (in Million US$), 2004-05 & 2005-06          
Table 7-10: Abbott - Key Financial (in Million Rs), May 2006       
Table 7-11: Ranbaxy - Key Financials (in Million Rs), 2005
Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.